IMS Health Reports First-Quarter 2015 Results

Go back to IMS Health Reports First-Quarter 2015 Results

IMS Health (IMS) Price Target Lifted to $33 at Piper Jaffray Post Q1

April 27, 2015 7:28 AM EDT

Piper Jaffray analyst Peter Appert reiterated an Overweight rating and boosted his price target on IMS Health Holdings (NYSE: IMS) to $33.00 (from $31.00) following Q1 results which showed platform strength.

Appert commented, "Upside to F1Q revenue, EBITDA and EPS, despite incremental F/X... More

IMS Health (IMS) Tops Q1 EPS by 7c

April 24, 2015 7:10 AM EDT

IMS Health (NYSE: IMS) reported Q1 EPS of $0.39, $0.07 better than the analyst estimate of $0.32. Revenue for the quarter came in at $632 million versus the consensus estimate of $626.89 million.

For earnings history and earnings-related data on IMS Health (IMS) click here.

... More